Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Evolution of Insulin Glargine and its Continuing Contribution to Diabetes Care
Rolf Hilgenfeld, Gerhard Seipke, Harald Berchtold, et al.
Drugs (2014) Vol. 74, Iss. 8, pp. 911-927
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
Mark A. Jarosinski, Balamurugan Dhayalan, Nischay Rege, et al.
Diabetologia (2021) Vol. 64, Iss. 5, pp. 1016-1029
Open Access | Times Cited: 89
Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus
Daniel A. Domingo‐Lopez, Giulia Lattanzi, Lucien H. J. Schreiber, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114280-114280
Open Access | Times Cited: 64
Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry
Mahdie Rahban, Faizan Ahmad, Mieczyslaw A. Piatyszek, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35947-35963
Open Access | Times Cited: 33
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study
Thomas Blevins, Dominik Dahl, Julio Rosenstock, et al.
Diabetes Obesity and Metabolism (2015) Vol. 17, Iss. 8, pp. 726-733
Open Access | Times Cited: 73
The Chemical Synthesis of Insulin: An Enduring Challenge
John A. Karas, John D. Wade, Mohammed Akhter Hossain
Chemical Reviews (2021) Vol. 121, Iss. 8, pp. 4531-4560
Closed Access | Times Cited: 52
Development of glucose-responsive ‘smart’ insulin systems
Nischay Rege, Nelson F. B. Phillips, Michael A. Weiss
Current Opinion in Endocrinology Diabetes and Obesity (2017) Vol. 24, Iss. 4, pp. 267-278
Open Access | Times Cited: 58
Insulin analogs: Glimpse on contemporary facts and future prospective
Arun Kumar Sharma, Gaurav Taneja, Ashish Kumar, et al.
Life Sciences (2019) Vol. 219, pp. 90-99
Closed Access | Times Cited: 48
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
Geremia B. Bolli, Alice Cheng, David R. Owens
Acta Diabetologica (2022) Vol. 59, Iss. 9, pp. 1129-1144
Open Access | Times Cited: 25
The developmental history of insulin pharmaceuticals
Hai Qian, Binbin Kou
Elsevier eBooks (2025), pp. 21-39
Closed Access
Pharmacokinetics, Pharmacodynamics, and Bioequivalence of Test Insulin Glargine Versus Reference Preparation (Lantus®) in Healthy Male Volunteers—By Euglycemic Clamp Technique
Zhongping Li, Min Liu, Yi Tao, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 418-418
Open Access
Expression and purification of recombinant human insulin from E. coli 20 strain
Marcin Zieliński, Agnieszka Romanik-Chruścielewska, Diana Mikiewicz, et al.
Protein Expression and Purification (2019) Vol. 157, pp. 63-69
Open Access | Times Cited: 36
Non-Covalent Albumin Ligands in FDA-Approved Therapeutic Peptides and Proteins
Florencio Zaragoza
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 6, pp. 3656-3663
Closed Access | Times Cited: 21
Comparing the Efficacy of Various Insulin Types: Pharmacokinetic and Pharmacodynamic Modeling of Glucose Clamp Effects in Healthy Volunteers
Yi-Chien Chang, William J. Jusko
The Journal of Clinical Pharmacology (2025)
Closed Access
U300, a novel long-acting insulin formulation
Gemma Sutton, Joan Minguet, C Ferrero, et al.
Expert Opinion on Biological Therapy (2014) Vol. 14, Iss. 12, pp. 1849-1860
Closed Access | Times Cited: 38
Comprehensive investigation of insulin-induced amyloidosis lesions in patients with diabetes at clinical and histological levels: A systematic review
Leyla Karkhaneh, Shaghayegh Hosseinkhani, Hossein Azami, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 7, pp. 103083-103083
Closed Access | Times Cited: 3
Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
Irene Hadjiyianni, Dominik Dahl, LB Lacaya, et al.
Diabetes Obesity and Metabolism (2016) Vol. 18, Iss. 4, pp. 425-429
Open Access | Times Cited: 30
Development of composite carbon quantum dots-insulin formulation for oral administration
Gamze Çamlık, Işıl Özakça, Besa Bilakaya, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103833-103833
Closed Access | Times Cited: 15
Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties – From an efficient E. coli expression system to a pharmaceutical formulation
Diana Mikiewicz, Anna Bierczyńska-Krzysik, Agnieszka Sobolewska, et al.
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0172600-e0172600
Open Access | Times Cited: 28
Equivalent Recombinant Human Insulin Preparations and their Place in Therapy
J. Sandow, Wolfgang Landgraf, R. H. A. Becker, et al.
touchREVIEWS in Endocrinology (2015) Vol. 11, Iss. 1, pp. 10-10
Open Access | Times Cited: 27
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
Thomas Först, Pratik Choudhary, Doron Schneider, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 6
Open Access | Times Cited: 23
Diselenide-bond replacement of the external disulfide bond of insulin increases its oligomerization leading to sustained activity
Kenta Arai, Masaki Okumura, Young‐Ho Lee, et al.
Communications Chemistry (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 7
Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes
Jayakrishnapillai P.V., Shantikumar V. Nair, Kaladhar Kamalasanan
Colloids and Surfaces B Biointerfaces (2017) Vol. 153, pp. 123-131
Closed Access | Times Cited: 24
Differential Pathway Coupling of the Activated Insulin Receptor Drives Signaling Selectivity by XMetA, an Allosteric Partial Agonist Antibody
Daniel Bedinger, Ira D. Goldfine, John Corbin, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 353, Iss. 1, pp. 35-43
Open Access | Times Cited: 23
Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000–2018
Sara Ramzan, Peter Timmins, Syed Shahzad Hasan, et al.
Primary care diabetes (2019) Vol. 13, Iss. 5, pp. 409-421
Open Access | Times Cited: 20
Comparative study on the deamidation of three recombinant human insulins using capillary electrophoresis
Melinda Andrási, Gayatri Vishwakarma, Ruben Szabo, et al.
Journal of Chromatography A (2023) Vol. 1706, pp. 464286-464286
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top